These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 25979650)
1. Expression of cell cycle regulators, 14-3-3σ and p53 proteins, and vimentin in canine transitional cell carcinoma of the urinary bladder. Suárez-Bonnet A; Herráez P; Aguirre M; Suárez-Bonnet E; Andrada M; Rodríguez F; Espinosa de Los Monteros A Urol Oncol; 2015 Jul; 33(7):332.e1-7. PubMed ID: 25979650 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors. Ramos-Vara JA; Miller MA; Boucher M; Roudabush A; Johnson GC Vet Pathol; 2003 Jan; 40(1):55-62. PubMed ID: 12627713 [TBL] [Abstract][Full Text] [Related]
3. Identification of survivin, an inhibitor of apoptosis, in canine urinary bladder transitional cell carcinoma. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Rucker EB; Knapp DW; Rodriguez CO; Green JA Vet Comp Oncol; 2008 Sep; 6(3):141-50. PubMed ID: 19178674 [TBL] [Abstract][Full Text] [Related]
4. Transitional cell carcinoma in fishing cats (Prionailurus viverrinus): pathology and expression of cyclooxygenase-1, -2, and p53. Landolfi JA; Terio KA Vet Pathol; 2006 Sep; 43(5):674-81. PubMed ID: 16966444 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of HER-2 via immunohistochemistry in canine urinary bladder transitional cell carcinoma - A marker of malignancy and possible therapeutic target. Millanta F; Impellizeri J; McSherry L; Rocchigiani G; Aurisicchio L; Lubas G Vet Comp Oncol; 2018 Jun; 16(2):297-300. PubMed ID: 28871659 [TBL] [Abstract][Full Text] [Related]
7. Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma. Vinall RL; Kent MS; deVere White RW Am J Vet Res; 2012 Oct; 73(10):1626-33. PubMed ID: 23013190 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of epithelial and mesenchymal cell markers in canine urinary bladder transitional cell carcinoma. Shinada M; Saeki K; Yoshitake R; Eto S; Tsuboi M; Chambers JK; Uchida K; Kato D; Yoshimoto S; Kamoto S; Ikeda N; Kinoshita R; Fujita N; Nishimura R; Nakagawa T Vet J; 2020 Dec; 266():105571. PubMed ID: 33323173 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of p63, Ki67 and β-catenin in canine transitional cell carcinoma and polypoid cystitis of the urinary bladder. Hanazono K; Nishimori T; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Uchide T Vet Comp Oncol; 2016 Sep; 14(3):263-9. PubMed ID: 24758385 [TBL] [Abstract][Full Text] [Related]
10. Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line. Kaewsakhorn T; Kisseberth WC; Capen CC; Hayes KA; Calverley MJ; Inpanbutr N Anticancer Res; 2005; 25(4):2689-96. PubMed ID: 16080513 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor expression in canine transitional cell carcinoma. Hanazono K; Fukumoto S; Kawamura Y; Endo Y; Kadosawa T; Iwano H; Uchide T J Vet Med Sci; 2015 Jan; 77(1):1-6. PubMed ID: 25223345 [TBL] [Abstract][Full Text] [Related]
13. P53 overexpression in bladder urothelial neoplasms: new aspect of World Health Organization/International Society of Urological Pathology classification. Kalantari MR; Ahmadnia H Urol J; 2007; 4(4):230-3. PubMed ID: 18270948 [TBL] [Abstract][Full Text] [Related]
14. Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma. Finotello R; Schiavo L; Ressel L; Frohmader A; Silvestrini P; Verin R J Comp Pathol; 2019 Jul; 170():1-9. PubMed ID: 31375151 [TBL] [Abstract][Full Text] [Related]
15. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer. Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222 [TBL] [Abstract][Full Text] [Related]
16. Assessment of HER2 Expression in Canine Urothelial Carcinoma of the Urinary Bladder. Tsuboi M; Sakai K; Maeda S; Chambers JK; Yonezawa T; Matsuki N; Uchida K; Nakayama H Vet Pathol; 2019 May; 56(3):369-376. PubMed ID: 30612533 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder. Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954 [TBL] [Abstract][Full Text] [Related]
18. Comparison of distributions of survivin among tissues from urinary bladders of dogs with cystitis, transitional cell carcinoma, or histologically normal urinary bladders. Rankin WV; Henry CJ; Turnquist SE; Turk JR; Beissenherz ME; Tyler JW; Green JA Am J Vet Res; 2008 Aug; 69(8):1073-8. PubMed ID: 18672973 [TBL] [Abstract][Full Text] [Related]
19. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder. Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659 [TBL] [Abstract][Full Text] [Related]
20. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder]. Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]